Real-world experience with mavacamten in obstructive hypertrophic cardiomyopathy: Observations from a tertiary care center
Authors:
- 13 February 2024
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 86, 62-68
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic CardiomyopathyJAMA Cardiology, 2016
- Results of Ventricular Septal Myectomy and Hypertrophic Cardiomyopathy (from Nationwide Inpatient Sample [1998–2010])The American Journal of Cardiology, 2014
- Predictors of Long-Term Outcomes in Symptomatic Hypertrophic Obstructive Cardiomyopathy Patients Undergoing Surgical Relief of Left Ventricular Outflow Tract ObstructionCirculation, 2013
- Long-Term Survival in Patients With Resting Obstructive Hypertrophic CardiomyopathyJACC, 2011
- Current Effectiveness and Risks of Isolated Septal Myectomy for Hypertrophic Obstructive CardiomyopathyThe Annals of Thoracic Surgery, 2008
- Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathyEuropean Heart Journal, 2006
- Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic CardiomyopathyJACC, 2005
- Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic CardiomyopathyCirculation, 2005
- Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2003
- Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young AdultsCirculation, 1995